Cardiome Announces The Addition Of Dr. Steen Juul-Möller As Medical Director, Europe
[at noodls] – Vancouver, Canada, March 28, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announces the addition of Steen Juul-Möller, M.D., Ph.D./DMSc., FESC to Cardiome’s management team as Medical … more
View todays social media effects on CRME
View the latest stocks trending across Twitter. Click to view dashboard